Drug: LOVENOX Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125288221 | LOVENOX | Hepatocellular injury | AVENTIS | 68.00 YR | F | 0 | 20160705 | FR |
125667221 | LOVENOX | Hepatocellular injury | AVENTIS | 95.00 YR | F | 70 KG | 20160718 | FR |
125723441 | LOVENOX | Hepatocellular injury | ASTRAZENECA | 34822.00 DY | F | 70 KG | 20160719 | FR |
125906412 | LOVENOX | Hepatocellular injury | ROCHE | 4.00 YR | M | 15 KG | 20160805 | FR |
125926761 | LOVENOX | Hepatocellular injury | VALIDUS | 95.00 YR | F | 0 | 20160726 | FR |
126706391 | LOVENOX | Hepatocellular injury | MERCK | 80.51 YR | M | 0 | 20160822 | FR |
126742371 | LOVENOX | Hepatocellular injury | AVENTIS | 80.00 YR | M | 0 | 20160822 | FR |
Total Records: 7 Number of Pages: 1